Salvatore Bryan J
Known title: Executive Vice PresidentCIK: 0001709075
Associated companies
Transaction History
| THG | ▲ Buy | Grant | 24 | $0 | 9/25/2026 | View on chart |
| THG | ▲ Buy | Grant | 25 | $0 | 6/26/2026 | View on chart |
| THG | ▲ Buy | Option Exercise | 16,394 | $1.7M | 6/3/2026 | View on chart |
| THG | ▼ Sell | Open Market | 16,394 | $3.0M | 6/3/2026 | View on chart |
| THG | ▲ Buy | Grant | 31 | $0 | 3/27/2026 | View on chart |
| THG | ▼ Sell | Tax Withholding | 2,807 | $507K | 2/27/2026 | View on chart |
| THG | ▲ Buy | Grant | 2,595 | $0 | 2/24/2026 | View on chart |
| THG | ▲ Buy | Grant | 1,672 | $0 | 2/24/2026 | View on chart |
| THG | ▲ Buy | Grant | 1,873 | $0 | 2/24/2026 | View on chart |
| THG | ▲ Buy | Grant | 27 | $0 | 12/26/2025 | View on chart |
| THG | ▼ Sell | Tax Withholding | 242 | $45K | 12/1/2025 | View on chart |
| THG | ▲ Buy | Grant | 27 | $0 | 9/26/2025 | View on chart |
| THG | ▲ Buy | Grant | 29 | $0 | 6/27/2025 | View on chart |
| THG | ▲ Buy | Option Exercise | 10,526 | $867K | 5/7/2025 | View on chart |
| THG | ▼ Sell | Open Market | 4,975 | $826K | 5/7/2025 | View on chart |
| THG | ▼ Sell | Open Market | 5,437 | $908K | 5/7/2025 | View on chart |
| THG | ▼ Sell | Open Market | 114 | $19K | 5/7/2025 | View on chart |
| THG | ▲ Buy | Grant | 28 | $0 | 3/28/2025 | View on chart |
| THG | ▲ Buy | Option Exercise | 10,526 | $867K | 3/3/2025 | View on chart |
| THG | ▼ Sell | Open Market | 1,500 | $256K | 3/3/2025 | View on chart |
| THG | ▼ Sell | Open Market | 3,992 | $686K | 3/3/2025 | View on chart |
| THG | ▼ Sell | Open Market | 5,034 | $869K | 3/3/2025 | View on chart |
| THG | ▼ Sell | Tax Withholding | 1,836 | $313K | 2/28/2025 | View on chart |
| THG | ▲ Buy | Grant | 1,777 | $0 | 2/25/2025 | View on chart |
| THG | ▲ Buy | Grant | 1,931 | $0 | 2/24/2025 | View on chart |
| THG | ▲ Buy | Grant | 353 | $0 | 2/24/2025 | View on chart |
| THG | ▲ Buy | Grant | 30 | $0 | 12/27/2024 | View on chart |
| THG | ▲ Buy | Grant | 29 | $0 | 9/27/2024 | View on chart |
| THG | ▲ Buy | Grant | 34 | $0 | 6/28/2024 | View on chart |
| THG | ▲ Buy | Grant | 31 | $0 | 3/28/2024 | View on chart |
| THG | ▲ Buy | Grant | 1,863 | $0 | 2/27/2024 | View on chart |
| THG | ▲ Buy | Grant | 1,694 | $0 | 2/26/2024 | View on chart |
| THG | ▲ Buy | Grant | 1,175 | $0 | 2/26/2024 | View on chart |
| THG | ▼ Sell | Tax Withholding | 1,700 | $229K | 2/26/2024 | View on chart |
| THG | ▲ Buy | Grant | 32 | $0 | 12/29/2023 | View on chart |
| THG | ▲ Buy | Grant | 34 | $0 | 9/29/2023 | View on chart |
| THG | ▲ Buy | Grant | 33 | $0 | 6/30/2023 | View on chart |
| THG | ▲ Buy | Grant | 29 | $0 | 3/31/2023 | View on chart |
| THG | ▼ Sell | Tax Withholding | 1,451 | $202K | 2/28/2023 | View on chart |
| THG | ▲ Buy | Grant | 1,765 | $0 | 2/27/2023 | View on chart |
| THG | ▲ Buy | Grant | 1,293 | $0 | 2/27/2023 | View on chart |
| THG | ▲ Buy | Grant | 1,608 | $0 | 2/27/2023 | View on chart |
| THG | ▲ Buy | Grant | 26 | $0 | 12/30/2022 | View on chart |
| THG | ▲ Buy | Grant | 25 | $0 | 9/30/2022 | View on chart |
| THG | ▲ Buy | Grant | 21 | $0 | 6/24/2022 | View on chart |
| THG | ▲ Buy | Grant | 21 | $0 | 3/25/2022 | View on chart |
| THG | ▼ Sell | Tax Withholding | 1,213 | $169K | 3/7/2022 | View on chart |
| THG | ▲ Buy | Grant | 1,838 | $0 | 2/28/2022 | View on chart |
| THG | ▲ Buy | Grant | 1,030 | $0 | 2/28/2022 | View on chart |
| THG | ▲ Buy | Grant | 1,434 | $0 | 2/28/2022 | View on chart |
| THG | ▲ Buy | Grant | 23 | $0 | 12/30/2021 | View on chart |
| THG | ▲ Buy | Grant | 21 | $0 | 9/24/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
Hanover Insurance (THG) Draws Attention for Growth and Valuation
Recent articles highlight Hanover Insurance as a potential growth candidate, citing strong capital allocation and a discounted valuation. These reports suggest the stock may be undervalued relative to its fundamentals. The company is currently trading near its 52-week high, with an average analyst target price of $235.88.
Hanover Insurance (THG) Draws Attention for Growth and Valuation. Recent articles highlight Hanover Insurance as a potential growth candidate, citing strong capital allocation and a discounted valuation. These reports suggest the stock may be undervalued relative to its fundamentals. The company is currently trading near its 52-week high, with an average analyst target price of $235.88.